ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (44)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vansteenkiste, J.F.
Right arrow Articles by Stroobants, S.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vansteenkiste, J.F.
Right arrow Articles by Stroobants, S.G.
Eur Respir J 2001; 17:802-820
Copyright ©ERS Journals Ltd 2001

The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology

J.F. Vansteenkiste1 and S.G. Stroobants2

1 Respiratory Oncology Unit, Dept of Pulmonology and 2 PET-Centre, Dept of Nuclear Medicine, University Hospital Gasthuisberg, Catholic University Leuven, Belgium

CORRESPONDENCE: J.F. Vansteenkiste, Respiratory Oncology Unit, Dept of Pulmonology, University Hospital Gasthuisberg, Herestraat 49, B-3000, Leuven, Belgium. Fax: 3216346803

Keywords: decision trees, emission computed tomography, 18F-fluoro-2-deoxy-d-glucose, lung neoplasms, non-small cell lung carcinoma, predictive value of tests

Received: October 12, 2000
Accepted January 10, 2001

This data was presented in part in the review-of-the-decade lecture at the 2000 Florence meeting of the European Respiratory Society

Abstract

In the past 5 yrs, positron emission tomography (PET) with 18F-fluoro-2-deoxy-d-glucose (FDG) has become an important imaging modality in lung cancer patients. At this time, the indication of FDG-PET as a complimentary tool to computed tomography in the diagnosis and staging of non-small cell lung cancer has gradually gained more widespread acceptance and also reimbursement in many European countries.

This review focuses on the data of FDG-PET in the diagnosis of lung nodules and masses, and in locoregional and extrathoracic staging of non-small cell lung cancer. Emphasis is put on the potential clinical implementation of the currently available FDG-PET data. The use of FDG-PET in these indications now needs further validation in large-scale multicentre randomized studies, focusing mainly on treatment outcome parameters, survival and cost-efficacy.

Interesting findings with 18F-fluoro-2-deoxy-d-glucose-positron emission tomography have also been reported for the evaluation of response to radio- or chemotherapy, in radiotherapy planning, recurrence detection and assessment of prognosis. Finally, a whole new field of application of positron emission tomography in molecular biology, using new radiopharmaceuticals, is under extensive investigation.




This article has been cited by other articles:


Home page
 JNMHome page
R. Boellaard
Standards for PET Image Acquisition and Quantitative Data Analysis
J. Nucl. Med., May 1, 2009; 50(Suppl_1): 11S - 20S.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
D. L. Fortes, M. S. Allen, V. J. Lowe, K.-H. R. Shen, D. A. Wigle, S. D. Cassivi, F. C. Nichols, and C. Deschamps
The sensitivity of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of metastatic pulmonary nodules
Eur. J. Cardiothorac. Surg., December 1, 2008; 34(6): 1223 - 1227.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
G. Veronesi, M. Bellomi, U. Veronesi, G. Paganelli, P. Maisonneuve, P. Scanagatta, F. Leo, G. Pelosi, L. Travaini, C. Rampinelli, et al.
Role of Positron Emission Tomography Scanning in the Management of Lung Nodules Detected at Baseline Computed Tomography Screening
Ann. Thorac. Surg., September 1, 2007; 84(3): 959 - 966.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
B. Fischer, J Mortensen, S. Langer, A Loft, A. Berthelsen, B. Petersen, G Daugaard, U Lassen, and H. Hansen
A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis
Ann. Onc., February 1, 2007; 18(2): 338 - 345.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. E. Daniels, V. J. Lowe, M.-C. Aubry, M. S. Allen, and J. R. Jett
The Utility of Fluorodeoxyglucose Positron Emission Tomography in the Evaluation of Carcinoid Tumors Presenting as Pulmonary Nodules
Chest, January 1, 2007; 131(1): 255 - 260.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
G. Plat, P. Pierard, A. Haller, J. Hutsebaut, J. Faber, M. Dusart, P. Eisendrath, J-P. Sculier, and V. Ninane
Endobronchial ultrasound and positron emission tomography positive mediastinal lymph nodes
Eur. Respir. J., February 1, 2006; 27(2): 276 - 281.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
L. Schrevens, N. Lorent, C. Dooms, and J. Vansteenkiste
The Role of PET Scan in Diagnosis, Staging, and Management of Non-Small Cell Lung Cancer
Oncologist, November 1, 2004; 9(6): 633 - 643.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J.F. Vansteenkiste
Imaging in lung cancer: positron emission tomography scan
Eur. Respir. J., February 1, 2002; 19(35_suppl): 49S - 60s.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
N.L. Muller
Advances in imaging
Eur. Respir. J., November 1, 2001; 18(5): 867 - 871.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the European Respiratory Society.